Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > Press > Abakan to Acquire Interest in Powdermet and its Advanced Material Technologies

Abstract:
Abakan Inc.'s (OTCQB: ABKIE) management is pleased to announce that it has entered into a stock purchase agreement to acquire a 41% interest in Powdermet, Inc.

Abakan to Acquire Interest in Powdermet and its Advanced Material Technologies

Miami, FL | Posted on September 11th, 2010

An initial payment of $500,000 has been paid with a closing for the remaining purchase price anticipated on or before September 30. The acquisition is expected to bring substantial value to Abakan's existing investment portfolio.

Powdermet, formed in 1996 and the winner of over 80 government-sponsored Phase 1, 2 and 3 grant programs, is currently transitioning from an engineered nano-powder R&D lab into a commercial sector company. According to Andrew Sherman, President and CEO of Powdermet, "We have been partnering with defense agencies for the last several years building some very advanced breakthrough material technologies. Having already worked closely with the Abakan team from their investment in MesoCoat, I recognize their capability to facilitate our commercialization strategy for Powdermet.".

According to Robert Miller, CEO of Abakan, "We have been so impressed by the innovative technology platforms now being commercialized at MesoCoat that when presented an opportunity to invest in their parent company, we welcomed the chance to participate. Powdermet has some of the most innovative products we have seen in our quest to invest in new surface modification technology companies. As an added benefit, Abakan increases its interest in the fast growing MesoCoat and will hold a direct and indirect 61% ownership position."

As Brian Doud, Engineering Manager of Powdermet pointed out, "Powdermet's breakout product platform of advanced materials solutions derived from our nano-engineered agglomerate technology include SComP™ and MComP™ energy absorbing ultra-lightweight syntactic- and nano-composite metals. These technologies will make quite an impact in the crash and ballistic/IED energy management markets with a 50% weight reduction and the ability to dissipate 500% more impact energy when compared to current aluminum alloys and foamed metals sold in the market."

Forward Looking Statements

A number of statements contained in this press release are forward-looking statements. These forward-looking statements involve a number of risks and uncertainties including technological obsolescence, market acceptance of future products, competitive market conditions, and the sufficiency of capital resources. The actual results Abakan may achieve could differ materially from any forward-looking statements due to such risks and uncertainties. Abakan encourages the public to read the information provided here in conjunction with its most recent filings on Form 10-K and Form 10-Q. Abakan's public filings may be viewed at www.sec.gov.

####

About Abakan
Abakan Inc. is a publicly traded company (symbol ABKIE) which invests in and manages companies that have developed transformational surface modification solutions and technologies. Miami based, they are now the single largest shareholder in MesoCoat, an Ohio based nanotechnology materials science company fast becoming a world leader in metal protection and repair through their revolutionary “long life” coating and “high speed” cladding technologies. MesoCoat’s solutions have already been the recipient of three prestigious R&D 100 awards, a Technology Innovation Program Award (TIP) for 100 year life coatings by the National Institute of Standards and Technology (NIST), and the NorTech Innovation Award for high performance environmentally friendly coating materials.

For more information, please click here

Contacts:
Abakan Inc.
Robert Miller
Chief Executive Officer
Phone: (786) 206-5368

Copyright © Abakan

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Bioengineered nanoparticles show promise for fibrinogen manufacture, says Journal of Pharmaceutical Analysis study: Scientists engineer a nanoparticle polymer that can selectively bind to fibrinogen in human plasma, presenting a pathway for improved drug development January 14th, 2022

Photon recycling – The key to high-efficiency perovskite solar cells January 14th, 2022

NSF funds Rice effort to measure, preserve quantum entanglement: Physicist Guido Pagano wins CAREER Award to develop tools for quantum computing January 14th, 2022

Tuning the bonds of paired quantum particles to create dissipationless flow: A tunable platform made from atomically thin materials may help researchers figure out how to create a robust quantum condensate that can flow without losing energy January 14th, 2022

Announcements

Nanostructures get complex with electron equivalents: Nanoparticles of two different sizes break away from symmetrical designs January 14th, 2022

New photonic effect could speed drug development: Twisted semiconductor nanostructures convert red light into the twisted blue light in tiny volumes, which may help develop chiral drugs January 14th, 2022

UT Southwestern develops nanotherapeutic to ward off liver cancer January 14th, 2022

The free-energy principle explains the brain January 14th, 2022

Military

Nanostructures get complex with electron equivalents: Nanoparticles of two different sizes break away from symmetrical designs January 14th, 2022

Physicists watch as ultracold atoms form a crystal of quantum tornadoes: The new observations record a key crossover from classical to quantum behavior January 7th, 2022

Series of preclinical studies supports the Army’s pan-coronavirus vaccine development strategy December 17th, 2021

Light speed advances: UD Prof. Tingyi Gu receives DARPA Young Faculty Award December 3rd, 2021

Financial Reports

180 Degree Capital Corp. Reports +14.2% Growth in Q1 2021, $10.60 Net Asset Value Per Share as of March 31, 2021, and Developments From Q2 2021 May 11th, 2021

Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021

Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021

180 Degree Capital Corp. Reports +6.7% Growth in Q4 2020, $9.28 Net Asset Value per Share as of December 31, 2020, and Developments from Q1 2021 Including Expected Investment in a Planned SPAC Sponsor February 22nd, 2021

Acquisitions/Mergers/Splits

The concept of creating «brain-on-chip» revealed: A team of scientists is working to create brain-like memristive systems providing the highest degree of adaptability for implementing compact and efficient neural interfaces, new-generation robotics, artificial intelligence, perso May 29th, 2020

180 Degree Capital Corp. Life Science Portfolio Company Enters Into Definitive Agreement to be Acquired May 6th, 2020

180 Degree Capital Corp.’s Portfolio Company, Synacor, Inc., Agrees to Merge with Qumu Corporation in All-Stock Transaction February 11th, 2020

Combination of Nanometrics and Rudolph Technologies to Create Onto Innovation October 16th, 2019

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project